1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News 13 APRIL 2015

Anti-Infective Drug News 13 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Viable Generic Sofosbuvir Market Will Increase Pricing Pressures For Gilead
Industry Brief - FDA Approves Sanofi's Quadracel DTaP-IPV Vaccine For Children Aged Four Through Six
Industry Brief - GSK To Provide Meningitis B Vaccine In UK
Industry Brief - EC Approves Kengrexal/Orbactiv/Raplixa
Industry Brief - AmpliPhi Granted EU Patent For Bacteriophage Therapy In Biofilm-Related Bacterial Infections
Industry Brief - Vantobra Granted EC Approval For Cystic Fibrosis
Industry Brief - Synthetic Biologics Initiates Phase IIa Trial Of SYN-004 In Microbiome/CDI
Industry Brief - Vernalis/Taisho Enter Drug Discovery Collaboration
Industry Trend Analysis - Emergent's Biodefence Products Will Fuel Development Of Its Commercial Pipeline
Industry Brief - Takeda Seeks Japanese Approval For Single Pack Containing Takecab For H. Pylori Eradication
Industry Trend Analysis - Diagnostics Are Key To Combatting Antibiotic Resistance
Industry Trend Analysis - Nabriva's Novel Antibiotic Will Draw In Further Attention After Stirring Investors
Industry Brief - Vical In-Licenses Antifungal Drug ASP2397 From Astellas
Industry Brief - Moberg Granted EU Patent Covering MOB-015 For Onychomycosis
Industry Brief - M72 TB Vaccine Trial Enters Final Phase
Industry Trend Analysis - Opportunities For Vaccine Manufacturers Still Exist Despite Waning Ebola Crisis
Industry Brief - FDA Grants Fast Track Designation For MedImmune's RSV Vaccine In LRTI Prevention
Industry Brief - Merck's Grazoprevir/Elbasvir Regimen Gains FDA Breakthrough Therapy Designations
Industry Trend Analysis - More Granular Studies Will Command Direction Of HCV Market
Industry Brief - Gardasil 9 HPV Vaccine Available In Canada
Industry Brief - CHMP Adopts Positive Opinion On Gardasil 9 HPV Vaccine
Industry Brief - FDA Warns Use Of Amiodarone With HCV Treatments Containing Sofosbuvir In Combination
Industry Brief - Copegus/Sovaldi Combination Therapy Approved In Japan For GT2 HCV
Industry Brief - BioCryst Awarded BARDA Contract To Support BCX4430 Development
Industry Brief - German Court Dismisses Microbix' Virusmax Lawsuit Against Novartis
Industry Brief - Sovaldi Approved In Japan For HCV GT2
Industry Brief - Ebola Test Vaccines Appear Safe In Phase II Liberian trial
Industry Brief - Harvoni Accepted For Public Reimbursement In Canada For HCV GT1
Industry Brief - B66-Based Prototype pandemic Flu Vaccine Gains Japanese Approval
Industry Brief - Ebola Vaccine Shows Promise In First Phase I trial
Industry Trend Analysis - Gilead To Maintain Dominance In HIV Market
Industry Brief - FDA Accepts Remune HIV/AIDS Vaccine BLA For Review
Industry Brief - GSK To Establish Global Vaccines R&D Centre In US
Industry Trend Analysis - Recent Agreements Highlight Sanofi Pasteur's Increasing Focus On Thermostable Vaccines
Industry Brief - Pfizer To Cease Vaccines Sales Business In China
Industry Brief - Novavax Raises Funds In Public Share Offering
Industry Brief - Insmed Raises Funds In Public Share Offering
Industry Brief - Rigontec Raises Funds To Advance RNA-Based Immunotherapeutics For Cancer/Viral Diseases
Industry Brief - Levon to Acquire SciVac
Industry Brief - Coronado Forms New Subsidiary DiaVax To Develop CMV Immunotherapies

Table Of Contents

Anti-Infective Drug News 13 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

“Veterinary/Animal Vaccines Market, Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, ...

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

Global Veterinary Vaccines Market

October 2016 $ 4 250

Download Unlimited Documents from Trusted Public Sources

Opioid Market in the US

  • October 2016
    32 pages
  • Opioid  


    Infectious Dise...  

  • United States  



View report >

Global Vaccine Industry

  • October 2016
    5 pages
  • Vaccine  

    Infectious Dise...  

  • World  



View report >

The future of the Vaccine Industry

  • October 2016
    3 pages
  • Vaccine  

  • United Kingdom  



View report >

Vaccine Industry

4 days ago

Related Market Segments :



Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.